1. Home
  2. BIAF vs PETZ Comparison

BIAF vs PETZ Comparison

Compare BIAF & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • PETZ
  • Stock Information
  • Founded
  • BIAF 2014
  • PETZ 2002
  • Country
  • BIAF United States
  • PETZ China
  • Employees
  • BIAF N/A
  • PETZ N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PETZ Steel/Iron Ore
  • Sector
  • BIAF Health Care
  • PETZ Industrials
  • Exchange
  • BIAF Nasdaq
  • PETZ Nasdaq
  • Market Cap
  • BIAF 13.0M
  • PETZ 10.9M
  • IPO Year
  • BIAF 2022
  • PETZ 2017
  • Fundamental
  • Price
  • BIAF $2.48
  • PETZ $1.06
  • Analyst Decision
  • BIAF Hold
  • PETZ
  • Analyst Count
  • BIAF 1
  • PETZ 0
  • Target Price
  • BIAF N/A
  • PETZ N/A
  • AVG Volume (30 Days)
  • BIAF 3.3M
  • PETZ 15.9K
  • Earning Date
  • BIAF 11-13-2025
  • PETZ 12-16-2025
  • Dividend Yield
  • BIAF N/A
  • PETZ N/A
  • EPS Growth
  • BIAF N/A
  • PETZ N/A
  • EPS
  • BIAF N/A
  • PETZ 0.26
  • Revenue
  • BIAF $7,681,059.00
  • PETZ $563,726.00
  • Revenue This Year
  • BIAF N/A
  • PETZ N/A
  • Revenue Next Year
  • BIAF $20.04
  • PETZ N/A
  • P/E Ratio
  • BIAF N/A
  • PETZ $5.19
  • Revenue Growth
  • BIAF 4.99
  • PETZ 74664.72
  • 52 Week Low
  • BIAF $2.34
  • PETZ $0.65
  • 52 Week High
  • BIAF $46.53
  • PETZ $1.68
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 46.44
  • PETZ 49.02
  • Support Level
  • BIAF $2.43
  • PETZ $1.03
  • Resistance Level
  • BIAF $3.50
  • PETZ $1.12
  • Average True Range (ATR)
  • BIAF 0.27
  • PETZ 0.06
  • MACD
  • BIAF -0.09
  • PETZ -0.00
  • Stochastic Oscillator
  • BIAF 6.42
  • PETZ 34.20

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About PETZ TDH Holdings Inc.

TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.

Share on Social Networks: